Grasim wants a slice of the Infra.Market ActionAn explainer on why Grasim seems to be interested in entering the B2B market in a very niche segment
A diagnosis of India’s diagnostic companiesAn explainer on the fate and fortune of diagnostic stocks in a post covid era